United States
Higher than US
Lower than US
US Average
Usage in last month, 2016-2017 National Survey on Drug Use and Health State Estimates
Marijuana & Legalization
If weed is medicine, so is Budweiser
1/17/19--Ten states and the District of Columbia have legalized recreational marijuana use, and another eight look likely to do so in 2019. In an editorial published in The Wall Street Journal by Peter Bach, Director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, Bach states that although he is in favor of the move, he is troubled by the gateway to it, and we should not pretend that legalized marijuana is therapeutic. Read
Top states for CBD retail shops?
1/11/19--As legal marijuana is slowly but surely finding its way into the mainstream, the modern pot shop has begun to provide a full-blown brand experience. And while the adoption of pro-marijuana legislation is still in its infancy in the U.S., cannabidiol (or CBD) is essentially available in all 50 states. Remedy Review combed Yelp Reviews to identify 1,000 most populous cities in America with the best-rated shops, the cheapest products, and the markets on the horizon. Read New Distilled Spirits Council study shows no impact on spirits sales from legalized recreational marijuana
1/10/19--Distilled spirits sales have not been negatively impacted in the three states that have had legalized recreational marijuana retail sales the longest, according to a study by the Distilled Spirits Council. This new in-depth analysis, utilizing state-level alcohol tax receipts and actual alcohol shipment data, examined per capita alcohol sales in Colorado, Washington state and Oregon for the two years prior to recreational marijuana legalization and up to 3-4 years post-legalization. Read Should ‘medical marijuana’ be recommended for patients?
1/10/19--According to Paul Terpeluk, DO, Medical Director, Employee Health Services, there are better alternatives than 'medical marijuana' for patients. Terpeluk believes that patients deserve to know that whatever they are using to control their symptoms is safe and effective. And clinicians need to have confidence that a treatment will work as intended. The goal of the healthcare provider is to help patients, to treat their conditions, to improve their quality of life and to ease their suffering ― within the bounds of scientific evidence. Read Constellation Brands stock sinks 11% after releasing disappointing 2019 outlook
1/9/19--Shares of Constellation Brands dropped 11 percent in premarket trading Wednesday morning. Constellation Brands said it expects to earn between $9.20 and $9.30 per share for the fiscal 2019 year, on an adjusted basis, missing analysts' expectations of $9.43 per share. The company's stock, which has a market value of $32.7 billion, struggled in 2018, with shares ending the year down 30 percent. Read Marijuana & Health
States that legalize medical marijuana also see higher birth rates
1/9/19--States that have legalized marijuana for medical purposes can expect a moderate increase in birth rates, according to a new study by two UConn researchers. The study, led by UConn’s Michele Baggio and David Simon, both assistant professors of economics, along with Alberto Chong of Georgia State University, found that a birth rate increase corresponded with an increased frequency of sexual intercourse, and decreased purchase and use of condoms. Read This reporter took a deep look into the science of smoking pot. What he found is scary.
1/5/19--New York Times reporter Alex Berenson’s new book, Tell Your Children, delves into research linking heavy marijuana use with violent crime and mental illness. Berenson interviewed researchers who have quietly but methodically documented the effects of THC on serious mental illness, and he makes a convincing case that a recreational drug marketed as an all-around health product may, in fact, be really dangerous—especially for people with a family history of mental illness and for adolescents with developing brains. Read Impacts of medical marijuana laws on young Americans across the developmental spectrum
1/4/19--State legalization of marijuana for medical purposes could increase illicit marijuana use among young people. Medical marijuana laws may boost the availability of marijuana and reduce perceptions of its harmfulness, leading more young people to try it. Prior studies report little evidence that these laws are impacting marijuana consumption by young Americans, and none have systematically compared developmentally distinct age groups. Read ‘Reefer Madness’ not so mad after all, anti-pot author warns
1/3/19--As marijuana continues its seemingly inevitable march to legalization in all 50 states, most Americans simply accept that it’s relatively harmless. But what if it’s not? Alex Berenson, a reporter and novelist who authored the book “Tell Your Children: The Truth About Marijuana, Mental Illness, and Violence” thoroughly presents the case for caution. Read Exposure to cannabis alters the genetic profile of sperm
12/19/18--New research from Duke Health suggests men in their child-bearing years should also consider how THC could impact their sperm and possibly the children they conceive during periods when they've been using the drug. Much like previous research that has shown tobacco smoke, pesticides, flame retardants and even obesity can alter sperm, the Duke research shows THC also affects epigenetics, triggering structural and regulatory changes in the DNA of users' sperm. Read Marijuana & Safety
Driving under the influence of cannabis among medical cannabis patients with chronic pain
1/9/19--Driving under the influence of cannabis (DUIC) is a public health concern among those using medical cannabis. Understanding behaviors contributing to DUIC can inform prevention efforts. A recent study evaluated three past 6-month DUIC behaviors among medical cannabis users with chronic pain. With more research needed on how to best measure DUIC, prevention messaging for DUIC may be enhanced by addressing alcohol co-consumption. Read NASA to launch safety review of SpaceX and Boeing after video of Elon Musk smoking pot rankled agency leaders
11/20/18--NASA has ordered a safety review of Boeing and SpaceX, the two companies it has hired to fly astronauts to the International Space Station. A months-long assessment would involve hundreds of interviews designed to assess the culture of the workplaces. The review was prompted by the recent behavior of SpaceX’s founder, Elon Musk after he took a hit of marijuana and sipped whiskey on a podcast streamed on the Internet. Read Legalized marijuana linked to a sharp rise in car crashes
10/18/18--There has been an increase by up to 6 percent in the number of highway crashes in four of the states where the recreational use of marijuana has been legalized, according to a pair of new studies. According to David Harkey, president of the Insurance Institute for Highway Safety’s Highway Loss Data Institute, the new reports do not prove there’s a direct risk caused by the use of marijuana among motorists, but they raise caution flags. Read States with legal marijuana see rise in car crashes, studies find
10/19/18--Car crashes were up as much as 6 percent in states where the recreational use of marijuana has been legalized. According to research from the Insurance Institute for Highway Safety and the Highway Loss Data Institute, the frequency of collision claims filed to insurers were higher in four states where marijuana is legal: Colorado, Nevada, Oregon, and Washington. Read
Inside the weird and wild crusade for clean pot
3/1/18--Figuring out what the rules should be to prevent impurities from contaminating pot is nearly impossible. There are no national standards like there are for food crops. “And unfortunately, pretty much all of the marijuana in the United States is drenched in harmful chemicals,” according to Rolling Stone reporter Amanda Chicago Lewis. “But let’s just say that if you like pot, you have absolutely exposed yourself to chemicals that can damage your central nervous system, mess with your hormones and give you cancer. Read Marijuana & Commerce
The marijuana billionaire who doesn’t smoke weed
1/16/19--Brendan Kennedy’s Canadian cannabis company Tilray has unexpectedly become America’s gateway to the legal marijuana industry. Tilray sells marijuana for medical use and, more recently, recreational use. It wears the crown as the hottest IPO of 2018, returning 315% for the year and valuing the Canada-based but American-run company at $9 billion today. To stay ahead, Kennedy, who actually had an antidrug upbringing, spends a lot of time trying to predict which country will be the next to legalize marijuana, so that Tilray will be there when it does. Read Pot unites democrats, republicans as ex-party chiefs join Tilray
12/13/18--Michael Steele and Dean Howard, former chairmen of the Republican and Democratic parties respectively, are among the heavyweights joining a Canadian company’s effort to boost the prestige of the marijuana industry. Tilray Inc., the first marijuana company to list directly on a U.S. exchange, announced the formation of a 10-person advisory board. Read People searched for a certain marijuana product a lot in 2018, Google says
12/10/18--People in the U.S. were really interested in learning about cannabidiol (CBD) gummies in 2018, according to Google’s year-end trend report. “CBD gummies” was the third most popular food-related Google search of the year—following unicorn cake and romaine lettuce. Read Aurora Cannabis to acquire Mexican company following partnership deal
12/10/18--Aurora Cannabis Inc. has signed a deal to acquire Mexican company Farmacias Magistrales. The deal to buy the pharmaceutical manufacturer and distributor follows an agreement last week that saw Aurora partner with the company. Read Wall Street’s top pot analyst loves Cronos deal for Altria: ‘Unique entry into cannabis’
12/10/18--Wall Street's top marijuana analyst, Vivien Azer, likes Marlboro maker Altria's $1.8 billion investment in Canadian pot company Cronos Group, telling clients the move represents a "unique entry into cannabis." According Azer, Cronos' emphasis on rare cannabinoids will likely prove valuable for Altria as it looks to diversify from tobacco and into up-and-coming markets like e-cigarettes and marijuana. Read Marijuana & Culture
Marijuana industry boosts DC lobbying team
1/11/19--The marijuana industry is boasting its largest lobbying team in Washington ever, as it gears up to push through major legislation in 2019. The Cannabis Trade Federation (CTF), a nonprofit to educate and advocate for cannabis in public policy, has hired 15 lobbyists to push the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act. The bill would protect state laws regulating marijuana use from the federal government. Read D.C. pot lobbyist : The future of marijuana legalization on Capitol Hill
1/10/19--Massachusetts is one of 10 states that has legalized recreational marijuana, but it's still illegal on the federal level, resulting in a confusing patchwork of conflicting laws. Michael Correia, known on Capitol Hill as "The Pot Lobbyist," is working to change this. WGBH Morning Edition anchor Joe Mathieu spoke with Correia while in Washington D.C. to talk about his efforts to legalize pot around the country and a recent attempt by Senator Elizabeth Warren to protect states that have already gotten that far. Read Madam Secretary pushes dangerous narrative on CBS
1/10/19--Sandra S. Bennett and William M. Bennett, MD, viewers of the CBS program "Madam Secretary" were stunned and dismayed when the show promoted the use and legalization of marijuana. According to the Bennett's, the alleged “facts” as presented in the program were misleading and/or incorrect. They are urging the network to change the next episode and all future episodes of Madam Secretary to remove any references suggesting that the use of marijuana or marijuana products, not approved by the FDA, are safe or beneficial. Read High Times has some glossy new competition
1/9/19--Marijuana culture is being reframed, in part as a result of independently run magazines with modest press runs but impressive coffee-table presence. They are helping the archetype of stereotypical marijuana smokers evolve into cultured, luxury-designer-wearing members of the creative class. Publishers see an exciting opportunity in a marketplace that could reach $23.4 billion in consumer spending and employ a half-million Americans by 2023, according to the cannabis data firm BDS Analytics. Read
Content, exposure, and effects of public discourses about marijuana
11/5/18--This review presents a comprehensive picture of research studies about marijuana-related content in news, social media, and advertisements. Studies that examined the extent of people’s exposure to the messages and its effects were also included. Read Marijuana & Enforcement
Ending weed prohibition hasn’t stopped drug crimes
12/7/18--A study recently published in The Economic Journal found that after medical marijuana was legalized in California, violent crime fell 15 percent. Yet, authorities in California’s Emerald Triangle, say that ever since California’s 1996 medical-marijuana initiative, violent crime in Humboldt, in particular, has increased. According to Ben Filippini, a deputy sheriff in this jurisdiction, "All legalization did here was create a safe haven for criminals.” Read Deputy Attorney General names U.S. Attorney Williams Chair of National Marijuana Working Group
11/7/18--Deputy Attorney General Rod J. Rosenstein today named Billy J. Williams, U.S. Attorney for the District of Oregon, chair of the Attorney General’s Marijuana Working Group. The working group is part of the Attorney General Advisory Committee’s (AGAC) Controlled Substances Subcommittee. Read Can Article V federally legalize cannabis?
8/12/18--Article V, a legal precedent set by America’s founding fathers, permits two-thirds of the states to call for a Convention of States to put forth proposed amendments to the Constitution. If the proposed amendment is passed by three-fourths of the states as they are comprised in Congress, then the Constitution will be amended. Article V has been considered to be the latest legal avenue to pursue to potentially challenge the current, federal administration’s predilection for prohibition. However, according to cannabis law expert, Bob Carp, pursuing an Article V legal strategy would be an exercise in futility. Apparently, Article V is not the best precedent for challenging federal prohibition. Read FDA rejects petition to further restrict marijuana
7/5/18--The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not "generally recognized as safe and effective." The move is "not necessary for the protection of public health," Janet Woodcock, the director of FDA's Center for Drug Evaluation and research wrote on Monday in a letter to the group, Drug Watch International. Read Judge allows hemp oil seller’s defamation suit to continue
6/15/18--U.S. District Judge John Steele will allow a hemp oil company’s defamation suit to continue against a Florida doctor interviewed by a local TV news station. The federal judge denied Dr. Joseph Dorn’s request to dismiss the lawsuit filed by AFI Holdings of Illinois last year over the doctor’s comments to a reporter about a hemp oil product. Read